Premier Path Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.73M Buy
7,275
+282
+4% +$288K 1% 21
2026
Q1
$6.43M Buy
6,993
+450
+7% +$456K 0.84% 28
2025
Q4
$7.03M Buy
6,543
+369
+6% +$353K 0.91% 26
2025
Q3
$4.71M Buy
6,174
+107
+2% +$79.6K 0.61% 35
2025
Q2
$4.73M Sell
6,067
-79
-1% -$61.4K 0.66% 35
2025
Q1
$5.08M Buy
6,146
+81
+1% +$67.4K 0.79% 32
2024
Q4
$4.68M Sell
6,065
-56
-0.9% -$46.4K 0.71% 34
2024
Q3
$5.42M Sell
6,121
-21
-0.3% -$18.9K 0.86% 25
2024
Q2
$5.56M Buy
6,142
+63
+1% +$50.4K 0.95% 22
2024
Q1
$4.73M Sell
6,079
-45
-0.7% -$32K 0.89% 22
2023
Q4
$3.55M Buy
+6,124
New +$3.57M 0.78% 29

Other funds holding LLY

Premier Path Wealth Partners's LLY Position: Q2 2026 in Review

Premier Path Wealth Partners increased its Eli Lilly (LLY) stake by 4% in Q2 2026, buying an estimated $288K and bringing the position to 7,275 shares worth $8.73M. The position accounts for 1% of the portfolio, ranked #21.

Premier Path Wealth Partners first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 2,086 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Premier Path Wealth Partners held 7,275 shares of Eli Lilly worth $8.73M as of Q2 2026.
  • Premier Path Wealth Partners bought 282 Eli Lilly shares in Q2 2026, an estimated $288K.
  • Eli Lilly made up 1% of Premier Path Wealth Partners's portfolio in Q2 2026, its #21 holding.
  • Premier Path Wealth Partners first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 2,086 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Premier Path Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.